Evidence map›Paper›PMID 35054777›Full record

ArticleInternational journal of molecular sciences2022

10-DEBC Hydrochloride as a Promising New Agent against Infection of

Da-Gyum Lee, Hye-Jung Kim, Youngsun Lee, Jung-Hyun Kim, Yoohyun Hwang, Jeongyeop Ha, Sungweon Ryoo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A laboratory perspective onFrontiers in microbiology · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Da-Gyum LeeCenter for Clinical Research, Masan National Tuberculosis Hospital, Changwon 51755, Korea.ORCID 0000-0003-3787-6455
Hye-Jung KimNew Drug Development Center, KBIO OSONG Medical Innovation Foundation, Cheongju 28160, Korea.
Youngsun LeeDivision of Intractable Diseases Research, Department of Chronic Diseases Convergence Research, Korea National Institute of Health, Cheongju 28160, Korea.
Jung-Hyun KimDivision of Intractable Diseases Research, Department of Chronic Diseases Convergence Research, Korea National Institute of Health, Cheongju 28160, Korea.ORCID 0000-0002-9496-9474
Yoohyun HwangCenter for Clinical Research, Masan National Tuberculosis Hospital, Changwon 51755, Korea.ORCID 0000-0003-0035-9171
Jeongyeop HaNew Drug Development Center, KBIO OSONG Medical Innovation Foundation, Cheongju 28160, Korea.
Sungweon RyooCenter for Clinical Research, Masan National Tuberculosis Hospital, Changwon 51755, Korea.ORCID 0000-0002-5085-0068
Masan National Tuberculosis Hospital · KRKorea National Institute of Health · KROsong Medical Innovation Foundation · KR

Funding

the Korea Health Technology R&D Project through the Korea Health Industry Development In-stitute (KHIDI) HI20C0478
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsMacrophagesMycobacterium abscessusMycobacterium Infections, NontuberculousProto-Oncogene Proteins c-aktHumansOxazinesProtein Kinase Inhibitors10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine10-DEBC hydrochlorideAnti-Bacterial AgentsOxazinesProtein Kinase InhibitorsProto-Oncogene Proteins c-akt10-DEBCdrug resistanceMycobacterium abscessusnonreplicating conditionsurrogate caseum binding assay

Identifiers

PMID35054777
PMCPMC8775589
OpenAlexW4206037029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.